NEW YORK (GenomeWeb) – NanoString Technologies said after the close of the market Tuesday that it will develop a companion diagnostic test for Celgene's Revlimid (lenalidomide), which the firm is developing for diffuse large B-cell lymphoma.
NEW YORK (GenomeWeb) — Idera Pharmaceuticals said today that it has entered into an agreement with Abbott to develop an in vitro companion diagnostic test for use in Idera's clinical development programs to treat certain genetically defined forms of B-cell lymphoma with its lead drug can
BD Diagnostics, a segment of Becton Dickinson, this week announced the availability of the US Food and Drug Administration-cleared BD MAX Enteric Bacterial Panel for use on the BD MAX system.
NEW YORK (GenomeWeb) – Cancer Genetics today said that it has received CLIA and New York State approvals to offer its mature B-cell neoplasm array for follicular lymphoma (MatBA-FL) and mantle-cell lymphoma (MatBA-MCL) as laboratory-developed tests.
NEW YORK (GenomeWeb News) – In BMC Genomics, researchers from the University of Edinburgh and elsewhere introduced a high-density SNP genotyping array developed for the Atlantic salmon, Salmo salar.
NEW YORK (GenomeWeb News) – Cancer Genetics and Roche Servicios today announced the expansion of an agreement covering molecular diagnostic testing in Central America and the Caribbean.
Roche Servicios is an affiliate of Roche.
NEW YORK (GenomeWeb Daily News) – Follicular lymphomas exhibit certain recurrent mutations and hew to common patterns as they undergo transformation, according to a new study published in Nature Gen
GE Healthcare this week released results from a pair of studies researching use of its MultiOmyx protein detection system in lymphoma and breast cancer.
Scientists from the Fred Hutchinson Cancer Research Center and recent spinout company Adaptive Biotechnologies have published research demonstrating that the use of a synthetic analogue of a somatically rearranged immune cell receptor locus can be used to quantify and correct mul
With the launch this month of its Hodgkin Lymphoma Profile diagnostic, GE Healthcare has moved its MultiOmyx protein detection system into the clinical arena.
